nanoTherics has announced the launch of the magnefect-LT. This device offers gene transfection with improved efficiencies and cell viabilities, even with difficult cells types including neuronal and primary cells.
Theraclone Sciences, Inc. has entered into a multi-year research and development collaboration with Pfizer. The collaboration will use Theraclone’s I-STAR technology to discover broadly protective monoclonal antibodies.
Six pharmaceutical manufacturing facilities constructed in Germany, Switzerland, Sweden, and the USA have been selected as Category Winners in the seventh annual Facility of the Year Awards (FOYA) program sponsored by ISPE, INTERPHEX, and Pharmaceutical Processing magazine.
MIT scientists have discovered that cells lining the blood vessels secrete molecules that suppress tumor growth and keep cancer cells from invading other tissues, a finding that could lead to a new way to treat cancer.
Convalescent plasma therapy—using plasma from patients who have recovered from an infection to treat those with the same infection—has been used to treat multiple diseases.
A recent study by researchers from Case Western Reserve University and scientists at Athersys, presents data supporting the potential therapeutic benefit of the MultiStem program for spinal cord injury.
A team of scientists has determined the structure of the protein package that delivers the genetic material of HIV to human cells. The work is the culmination of studies looking at different portions of the cone-shaped container, or the capsid.
Scientists have found that a known enzyme in cells protects against measles virus, likely by altering the virus’s genetic material, RNA. Cells lacking the enzyme become highly vulnerable to the virus’s destructive effects.
Innovative LIMS developer, Two Fold Software Limited, is releasing new software that enables the company’s Qualoupe LIMS user interface to display results parameters with clarity and flexibility.
Linguamatics announced the launch of its new online version of the I2E text mining platform. I2E OnDemand offers smaller companies the advanced, high performance text mining capabilities that big pharma companies have been using for years.
BioClinica, Inc. has established a strategic partnership with Symbiance Inc., a specialty contract research organization. Symbiance concentrates in therapeutic areas relevant to pharmaceutical and biotechnology companies with particular focus in oncology and CNS.
Evotec AG announced that it has entered into a collaboration with Takeda Cambridge Limited, to identify small molecule modulators against GPCR and Protease targets involved in various CNS and Metabolic diseases.
The National Cancer Institute estimates that more than 43,000 Americans were diagnosed with pancreatic cancer last year and more than 36,000 died from the disease. The Ras oncogene is mutated in virtually all pancreatic cancers.
Ebola, a virus that causes deadly hemorrhagic fever in humans, has no known cure or vaccine. But a new study has uncovered a family of small molecules which appear to bind to the virus's outer protein coat and may inhibit its entry into human cells.
Novo Nordisk announced that a US District Court judge ruled that one of its patents, which covers the combination use of repaglinide and metformin for the treatment of type 2 diabetes, is invalid and unenforceable.